Stay updated on Atezolizumab in Esophageal Cancer: Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in Esophageal Cancer: Clinical Trial page.

Latest updates to the Atezolizumab in Esophageal Cancer: Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe web page has been updated to reflect new information regarding the clinical study for Esophageal Squamous Cell Carcinoma, including an increase in the number of study locations from 163 to 166 and the addition of specific locations in Chengdu, Chongqing, and Lyon. The study's timeline has also been updated with new dates in April 2025.SummaryDifference14%
- Check34 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 9, 2025.SummaryDifference0.3%
- Check41 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a more recent last update date (2025-03-25), replacing the previous version (v2.14.2) and its last update date (2025-01-09).SummaryDifference0.2%
- Check77 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check92 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
Stay in the know with updates to Atezolizumab in Esophageal Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in Esophageal Cancer: Clinical Trial page.